Bladder cancer treatment is undergoing a significant transformation, marked by advances in diagnostics, novel therapies, and evolving treatment strategies. Innovations such as liquid biomarkers and MRI are enhancing diagnostic precision, while new drug classes are expanding options for non-muscle invasive bladder cancer (NMIBC) and metastatic disease.
This event will provide a comprehensive overview of these groundbreaking changes and their implications for clinical practice.
By attending this meeting, you will:
This event offers a unique opportunity to engage with leading experts in urologic oncology, explore the latest evidence-based advances, and prepare for the next chapter in bladder cancer care.
Early Bird pricing available until 18 August 2025.
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £77.00 | £46.00 | £46.00 | £46.00 | £24.00 |
| Consultant / GP / SAS Doctors | AHP / Nurse / Midwife | Trainee | Student |
|---|---|---|---|
| £141.00 | £84.00 | £84.00 | £44.00 |
Professor Nick James, Professor of Prostate and Bladder Cancer Research, The Institute of Cancer Research, London
Speaker to be confirmed
Speaker to be confirmed
Panel discussion
Professor Rik Bryan, University of Birmingham
Speaker to be confirmed
Speaker to be confirmed
Professor Jim Catto, University of Sheffield
Panel discussion
AGM for section members only
Professor Jim Catto, University of Sheffield
Speaker to be confirmed
Professor Tom Powles, Barts Cancer Institute
Professor Syed Hussain, University of Sheffield
Professor Rik Bryan, University of Birmingham
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00 am on Monday 29 September 2025. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in the future on various Internet channels.
